In recent years, diagnostics in the field of medicine has developed at an extremely rapid pace, thanks to the use and improvement of new medical devices and devices. The problem of timely and adequate diagnosis and treatment of the syndrome of obstructive sleep apnea (OSA) and snoring is particularly relevant worldwide. The disease has been proven to worsen the patients’ quality of life, and may even threaten it. Obstructive sleep apnea and snoring syndrome (OSAS) is a widespread disease of social importance in which there is a reduction or cessation of airflow through the nose/mouth during sleep due to upper airway collapse. Obstructive sleep apnea affects the cardiovascular, endocrine, neurocognitive and other systems of the body. There are symptoms of loud snoring, choking, hypoxemia, and micro-awakenings, leading to sleep fragmentation, daytime fatigue, and sleepiness. The latter greatly worsens the quality of life of patients. There are real risks to the life and health of the patient and others, given the possibility of falling asleep at the wheel in drivers with sleep apnea and participation in traffic accidents. To diagnose the syndrome, a polysomnographic study is performed, which is still the gold standard. For a better diagnosis, it is recommended to combine it with rhinomanometry. Treatment of OSA includes control of risk factors and removal of obstructive factors that make breathing difficult. Severe OSA syndrome is treated with continuous positive pressure ventilation (CPAP) during sleep, possibly in combination with intraoral devices. Rhinomanometry can also be used to monitor the effectiveness of CPAP therapy in severe forms of the syndrome by determining tissue resistance. The impact on patients with a milder form of OSA treated with intraoral devices is also monitored. The method can also be used in patients with allergic rhinitis, sinusitis of rhinogenic and other origin, and patients with orthodontic deformities. The correct choice of intraoral appliances for conservative treatment of OSA and timely diagnosis are key to successful treatment.
Bousquet J, Cruz AA, Robalo-Cordeiro C. Obstructive sleep apnoea syndrome is an under-recognized cause of uncontrolled asthma across the life cycle. Rev Port Pneumol (2006). 2016;22(1):1-3. doi: 10.1016/j.rppnen.2015.12.006.
De Vito A, Berrettini S, Carabelli A, Sellari-Franceschini S, Bonanni E, Gori S, et al. The importance of nasal resistance in obstructive sleep apnea syndrome: a study with positional rhinomanometry. Sleep Breath. 2001;5(1):3-11. doi: 10.1007/s11325-001-0003-y.
Atkins M, Taskar V, Clayton N, Stone P, Woodcock A. Nasal resistance in obstructive sleep apnea. Chest. 1994;105(4):1133-5. doi: 10.1378/chest.105.4.1133.
Masdeu MJ, Seelall V, Patel AV, Ayappa I, Rapoport DM. Awake measures of nasal resistance and upper airway resistance on CPAP during sleep. J Clin Sleep Med. 2011;7(1):31-40.
Hsu YB, Liu SY, Lan MY, Huang YC, Tzeng IS, Lan MC. Role of rhinomanometry in the prediction of therapeutic positive airway pressure for obstructive sleep apnea. Respir Res. 2020 May 13;21(1):115. doi: 10.1186/s12931-020-01382-4.
Hueto J, Santaolalla F, Sanchez-Del-Rey A, Martinez-Ibargüen A. Usefulness of rhinomanometry in the identification and treatment of patients with obstructive sleep apnoea: an algorithm for predicting the relationship between nasal resistance and continuous positive airway pressure. a retrospective study. Clin Otolaryngol. 2016;41(6):750-7. doi: 10.1111/coa.12639.
Cole P, Fenton RS. Contemporary rhinomanometry. J Otolaryngol. 2006;35(2):83-7. doi: 10.2310/7070.2005.5016.
Email this article (Login required) 
